Stefan Gingele
Overview
Explore the profile of Stefan Gingele including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
797
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hudasch D, Klietz M, Skripuletz T, Gingele S, Jendretzky K, Konen F, et al.
J Neurol
. 2025 Feb;
272(2):172.
PMID: 39891750
No abstract available.
2.
Konen F, Mohn N, Witte T, Schefzyk M, Wiestler M, Lovric S, et al.
Autoimmun Rev
. 2025 Jan;
24(4):103754.
PMID: 39842533
A wide variety of immunomodulatory therapies are already available for the treatment of multiple sclerosis (MS). Through fundamental insights from basic research with a gain of knowledge in the pathological...
3.
Jendretzky K, Lezius L, Thiele T, Konen F, Huss A, Heitmann L, et al.
Neurol Res Pract
. 2024 Nov;
6(1):55.
PMID: 39533435
Background: Diagnosing multiple sclerosis (MS) is challenging due to diverse symptoms and the absence of specific biomarkers. Concurrent autoimmune diseases (AID) or non-specific antibodies further complicate diagnosis, progression monitoring, and...
4.
Haar M, Konen F, Gehlhaar M, Oluwatoba-Popoola I, Donicova E, Wachsmann M, et al.
Ther Adv Ophthalmol
. 2024 Nov;
16:25158414241294024.
PMID: 39493254
Background: Sjögren's syndrome is an autoimmune disease characterized by sicca symptoms and various extraglandular manifestations including vasculitis. Neurological involvement occurs frequently (Neuro-Sjögren) and often mimics immune neuropathies such as chronic...
5.
Konen F, Gingele S, Hummert M, Mohn N, Streichert A, Kretschmer J, et al.
Mult Scler Relat Disord
. 2024 Sep;
91:105886.
PMID: 39299183
Background: The humanized monoclonal anti-CD20-antibody ofatumumab is highly effective in treating relapsing multiple sclerosis (MS). Objective: This study aimed to investigate the immanent effect of ofatumumab on the peripheral immune...
6.
Passoke S, Stern C, Haussler V, Kumpfel T, Havla J, Engels D, et al.
J Neurol Neurosurg Psychiatry
. 2024 Jul;
PMID: 39084862
Background: Data on cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are limited to studies with small sample sizes. Therefore, we aimed to analyse the extent, characteristics and...
7.
Wohnrade C, Seeliger T, Gingele S, Bjelica B, Skripuletz T, Petri S
J Neurol
. 2024 Jul;
271(9):6400.
PMID: 39068610
No abstract available.
8.
Wohnrade C, Seeliger T, Gingele S, Bjelica B, Skripuletz T, Petri S
J Neurol
. 2024 Apr;
271(7):4441-4452.
PMID: 38683209
Objective: To evaluate the performance of serum neurofilament light chain (NfL) and cerebrospinal fluid (CSF) phosphorylated neurofilament heavy chain (pNfH) as diagnostic biomarkers for the differentiation between motor neuron disease...
9.
Jendretzky K, Bajor A, Lezius L, Hummert M, Konen F, Grosse G, et al.
Sci Rep
. 2024 Mar;
14(1):7293.
PMID: 38538701
Optic neuritis is often an initial symptom in multiple sclerosis (MS) or clinically isolated syndrome (CIS), yet comprehensive studies using the 2017 McDonald criteria for MS are scarce. Patient records...
10.
Seeliger T, Gingele S, Guzeloglu Y, Heitmann L, Luling B, Kohle F, et al.
Front Neurol
. 2024 Jan;
14:1330484.
PMID: 38264088
Introduction: Blood-cerebrospinal fluid (CSF) barrier dysfunction is pivotal for diagnosing immune-mediated neuropathies, especially in spinal nerve root inflammation. Typically, either total CSF protein or the CSF to serum albumin ratio...